Galventa stands for galenic innovation. Our mission is to improve the efficacy of nutraceuticals through better delivery technologies that feature unique release profiles & best-in-class bioavailability. Our technologies are patented, clinically proven, published, and serve as platforms that are applicable in OTC/Nutra. Galventa showcases its technologies under its own consumer brand “B・SYNC®” with products that improve the hallmarks of sleep, mental health and rejuvenation.
| Website | http://www.galventa.com |
| Employees | 5 (2 on RocketReach) |
| Founded | 2021 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Bioavailability Enhancement, Nutraceutical Formulation, Controlled Release Technology, Drug Delivery Systems, Pharmaceutical Technologies, Advanced Drug Delivery, Pharmaceutical Development |
| Competitors | CureVac, Moderna Therapeutics, INOVIO Pharmaceuticals, Inc., Pfizer, Genentech, Sanofi, AstraZeneca, Novartis, Lilly India, Roche +38 more (view full list) |
Looking for a particular Galventa AG employee's phone or email?
Galventa AG Questions
Sascha Fritsche is the Co-Founder, CEO of Galventa AG.
2 people are employed at Galventa AG.
Top Galventa AG Employees
-
Sascha Fritsche
Co-Founder, CEO at Galventa AG
Zürich, ZH, CH12
Related Companies
G2Crowd Trusted
300K+
Plugin Users
